Table 1.
Screening visit | Baseline visit | 2-week visit | 6-week visit | 12-week visit | |
---|---|---|---|---|---|
Informed consent | X | ||||
Demographics | X | ||||
Medical history | X | ||||
Medication form | X | ||||
Comorbidity assessment | X | ||||
VAS for pain | X | X | X | X | X |
FIHOA | X | X | X | X | X |
Assessment of stiffness | X | X | X | X | |
Patient global assessment | X | X | X | X | |
Aqol-4D | X | X | X | X | |
Use of rescue medication | X | X | X | ||
Joint examination | X | X | X | X | |
Grip and pinch strength | X | X | X | X | |
WPAI-GH | X | X | X | X | |
Global rating of change | X | X | |||
First MCP joint assessment | X | ||||
Treatment expectation | X | ||||
Treatment adherence | X | X | X | ||
Clinical safety assessment | |||||
Blood pressure | X | X | X | X | |
Adverse events | X | X | X | ||
Radiology/imaging | |||||
PA view radiograph | X | ||||
Eaton stress view radiograph | X | ||||
Hand ultrasonography | X |
AqoL-4D, Assessment of Quality of Life—4D; FIHOA, Functional Index for Hand Osteoarthritis; MCP, metacarpophalangeal; PA, posteroanterior; VAS, Visual Analogue Scale; WPAI-GH, Work Productivity and Activity Impairment Questionnaire-General Health.